LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 130 filers reported holding LOXO ONCOLOGY INC in Q2 2017. The put-call ratio across all filers is 2.66 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $25,447,000 | -12.2% | 181,675 | +7.1% | 12.65% | +6.3% |
Q3 2018 | $28,986,000 | +5.3% | 169,675 | +6.9% | 11.90% | -7.6% |
Q2 2018 | $27,527,000 | +31.4% | 158,675 | -12.6% | 12.89% | +26.5% |
Q1 2018 | $20,944,000 | -15.9% | 181,537 | -38.7% | 10.19% | -24.1% |
Q4 2017 | $24,917,000 | +3.2% | 296,000 | +12.9% | 13.42% | -10.5% |
Q3 2017 | $24,147,000 | -0.8% | 262,121 | -13.7% | 14.99% | -13.7% |
Q2 2017 | $24,347,000 | +92.4% | 303,621 | +1.0% | 17.37% | +62.3% |
Q1 2017 | $12,654,000 | +182.0% | 300,722 | +115.2% | 10.70% | +171.5% |
Q4 2016 | $4,487,000 | +31.6% | 139,722 | +7.3% | 3.94% | +66.0% |
Q3 2016 | $3,409,000 | +44.2% | 130,222 | +27.7% | 2.37% | +26.7% |
Q2 2016 | $2,364,000 | +121.8% | 101,966 | +161.5% | 1.87% | +103.7% |
Q1 2016 | $1,066,000 | -39.3% | 39,000 | -36.8% | 0.92% | -41.2% |
Q4 2015 | $1,756,000 | +756.6% | 61,737 | +425.6% | 1.56% | +670.9% |
Q3 2015 | $205,000 | -7.2% | 11,745 | -4.1% | 0.20% | +8.6% |
Q2 2015 | $221,000 | – | 12,245 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital LLC | 3,438,920 | $289,488,000 | 57.19% |
DAFNA Capital Management LLC | 296,000 | $24,917,000 | 13.42% |
Casdin Capital, LLC | 360,000 | $30,305,000 | 7.38% |
Opaleye Management Inc. | 176,300 | $14,841,000 | 4.75% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 574,495 | $48,361,000 | 1.84% |
SECTORAL ASSET MANAGEMENT INC | 152,185 | $12,811,000 | 1.60% |
AWM Investment Company, Inc. | 85,000 | $7,155,000 | 1.39% |
Eventide Asset Management | 285,000 | $23,991,000 | 1.25% |
Rock Springs Capital Management LP | 310,000 | $26,096,000 | 1.18% |
Crawford Lake Capital Management, LLC | 53,420 | $4,497,000 | 1.06% |